USD
+$0.00
(+0.00%
)At Close (As of Sep 26, 2025)
$9.64B
Market Cap
36.1
P/E Ratio
2.3
EPS
$129.22
52 Week High
$81.36
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | $1.3B |
Total Revenue | $2.8B |
Cost Of Revenue | $1.4B |
Costof Goods And Services Sold | $1.4B |
Operating Income | $411M |
Selling General And Administrative | $994M |
Research And Development | $197M |
Operating Expenses | $912M |
Investment Income Net | - |
Net Interest Income | -$23M |
Interest Income | $73M |
Interest Expense | $96M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $428M |
Income Before Tax | $316M |
Income Tax Expense | $33M |
Interest And Debt Expense | - |
Net Income From Continuing Operations | $283M |
Comprehensive Income Net Of Tax | - |
Ebit | $412M |
Ebitda | $840M |
Net Income | $296M |
Field | Value (USD) |
---|---|
Total Assets | $12B |
Total Current Assets | $2.3B |
Cash And Cash Equivalents At Carrying Value | $1.2B |
Cash And Short Term Investments | $1.2B |
Inventory | $368M |
Current Net Receivables | $632M |
Total Non Current Assets | $10B |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | $2.6B |
Intangible Assets Excluding Goodwill | $2.6B |
Goodwill | $6.5B |
Investments | - |
Long Term Investments | - |
Short Term Investments | $0 |
Other Current Assets | $186M |
Other Non Current Assets | - |
Total Liabilities | $4.7B |
Total Current Liabilities | $653M |
Current Accounts Payable | $167M |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $24M |
Total Non Current Liabilities | $4.1B |
Capital Lease Obligations | $175M |
Long Term Debt | $3.2B |
Current Long Term Debt | $242K |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $3.3B |
Other Current Liabilities | $322M |
Other Non Current Liabilities | $771M |
Total Shareholder Equity | $7.7B |
Treasury Stock | - |
Retained Earnings | $5.8B |
Common Stock | $121M |
Common Stock Shares Outstanding | $123M |
Field | Value (USD) |
---|---|
Gross Profit | $1.3B |
Total Revenue | $2.8B |
Cost Of Revenue | $1.4B |
Costof Goods And Services Sold | $1.4B |
Operating Income | $411M |
Selling General And Administrative | $994M |
Research And Development | $197M |
Operating Expenses | $912M |
Investment Income Net | - |
Net Interest Income | -$23M |
Interest Income | $73M |
Interest Expense | $96M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $428M |
Income Before Tax | $316M |
Income Tax Expense | $33M |
Interest And Debt Expense | - |
Net Income From Continuing Operations | $283M |
Comprehensive Income Net Of Tax | - |
Ebit | $412M |
Ebitda | $840M |
Net Income | $296M |
Sector: HEALTHCARE
Industry: DIAGNOSTICS & RESEARCH
Revvity, Inc. is a leading provider of innovative products and solutions tailored for the diagnostics, life sciences, and applied services markets on a global scale. Headquartered in Waltham, Massachusetts, the company leverages cutting-edge technology to enhance diagnostic processes and improve overall healthcare outcomes. With a focus on delivering high-quality services and solutions, Revvity is well-positioned to capitalize on the growing demand for advanced diagnostic tools and life science innovations, making it an attractive investment opportunity for institutional investors.